BANK OF MONTREAL /CAN/ - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 45 filers reported holding NEOS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$0115
+1816.7%
0.00%
Q1 2019$0
-100.0%
6
-99.1%
0.00%
Q4 2018$1,000
-75.0%
661
-33.6%
0.00%
Q3 2018$4,000
-33.3%
996
-0.5%
0.00%
Q2 2018$6,000
+50.0%
1,001
+100.2%
0.00%
Q1 2018$4,000500
+6150.0%
0.00%
Q3 2017$08
+300.0%
0.00%
Q2 2017$0
-100.0%
2
-100.0%
0.00%
Q1 2017$58,0008,000
+33233.3%
0.00%
Q4 2016$024
-47.8%
0.00%
Q3 2016$046
+130.0%
0.00%
Q2 2016$020
+185.7%
0.00%
Q1 2016$0
-100.0%
7
-75.0%
0.00%
Q3 2015$1,000280.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders